P to P Manufacturing
FORMULATIONS ON OFFER
Emollient
Development of patient friendly formulation
Topical Steroid
Antifungal agent
Topical Anti-Bacterial
Acne management
Dermatological Formulations
Emollient
Pain Killer
Topical Steroid with Keratolytic
Topical Steroid with Antifungal
Topical Steroid with Anti-Bacterial
Dermatological Combinations
Emollient
Anti-aging
Cleansing Lotion
Hair Care Products
Anti-Dandruff shampoo
Sunscreen
Anti-Acne
Cosmeceuticals
Anti-Oxidant tablets
Anti-Oxidants combination
Nutraceuticals
Proton Pump Inhibitor
Anti-Malarial
Anti-Bacterial
Corticosteroid Hormones
Cephalosporins
Dry Powder injection
Proton Pump Inhibitor
Anti-Fungal
Anti-Bacterial
Muscle Relaxant
Bone Resorption Inhibitor
Anti-Oxidant/ Liver diseases
Antibiotic
Lyophilized products
Innovative Formulations
Lyka Labs is actively associated in the innovation and development of new drug formulation. Lyka also provides medical and technical expertise about manufacturing know how, manufacturing facilities, technical data such as molecule stability testing data, impurity profile, BA/BE clinical study data etc. Lyka has emerged as a key player in development of specialized formulations of which some are developed with the success and are offered to the key market on a ‘principal to principal’ basis
Services
Lyka is engaged in providing manufacturing services to various large pharmaceutical companies. In this case, all raw materials and packaging materials are provided by client, and Lyka functions as a contracted manufacturer.
The reasons for which companies choose Lyka are:
Dedicated team of Professional enthusiasts
Consistent Quality
Technical & clinical data support
Technical Competency
Timely Delivery
Our Clients
Lyka is engaged in providing manufacturing services to various large pharmaceutical companies. In this case, all raw materials and packaging materials are provided by client, and Lyka functions as a contracted manufacturer.
Lyka Labs Ltd.
INTRODUCTION
Lyka Healthcare Ltd.- The domestic arm of Lyka Labs Ltd. whose products and technologies span the continuum of care in varied therapeutic segment.
Our comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years. Lyka Labs Ltd. is known for its innovative products and a commitment to applying leading edge science and technologies to advance patient care. Our product and services are designed to maintain our reputation for high quality and optimal performance.
THE SUCCESS OF LYKA HEALTHCARE LTD
The success of Lyka Labs Ltd. is driven by a combination of a highly competent and motivated commercial team, R&D backed products, aided by strong alliances. The company has in-house development and medical teams to undertake product and clinical development tailored to needs of the Indian market.
Lyka Labs Ltd. enjoys strong brand equity in multiple therapeutic categories such as Intensive care, Gastroenterology, Anti-Infective, Anti-fungal, Surgery care & other therapy areas. On this anvil is the expansion of range of the products in above therapeutic segments as well as in new therapeutic segment likes Cosmetologist, Urology, Wound care & Anesthesia.
Healthcare Division
| PRODUCT LIST | |||
|---|---|---|---|
| SR NO | GENERIC NAME /COMPOSITION | BRAND NAME | PKG |
| 01 | Amphotericin - B 50mg. | AMPHOLYN 50mg. Inj. | Vial |
| 02 | Artesunate 60mg. | ALYSUNATE 60mg. Inj. | Vial |
| 03 | Sterile Cefuroxime Sodium IP eq. to Cefuroxime 1500mg | CEFAHEAD 1.5 gm Inj. | Vial |
| 04 | Cefuroxime Axetil IP Eq.to Anhydrous Cefuroxime 500mg | CEFAHEAD 500mg (10 Tabs) | Vial |
| 05 | Cefepime Hydrochloride 1g.+ Tazobactam Sodium-125mg | LYFIPIME –TZ 1.125gm Inj. | Vial |
| 06 | Cefepime Hydrochloride 250mg. .+ Tazobactam Sodium-31.25mg | LYFIPIME -TZ 250mg Inj. | Vial |
| 07 | Cefoperazone 1g. + Sulbactam 500mg. | LYPEX -SB 1.5g Inj. | Vial |
| 08 | Cefoperazone 500mg. + Sulbactam 500mg. | LYPEX -SB 1 g Inj. | Vial |
| 09 | Cefoperazone 2g. + Sulbactam 1g | LYPEX -SB 3 g Inj. | Vial |
| 10 | Cefoperazone 1g. + Tazobactam 125mg. | LYPEX -TZ 1.125gm Inj. | Vial |
| 11 | Ceftazidime 1g. + Tazobactam Sodium 125mg. | ZIMTAZ 1.125gm Inj. | Vial |
| 12 | Ceftriaxone 1g | XOLYCEF 1g Inj. | Vial |
| 13 | Ceftriaxone Sodium 1g + Tazobactam Sodium 125mg. | XOLYCEF - TZ Inj. | Vial |
| 14 | Ceftriaxone Sodium 1g +Sulbactam Sodium 500mg. | XOLYCEF - SB 1.5g. Inj. | Vial |
| 15 | Colistimethate Sodium BP 10,00,000 IU | COLIPRIME 1 MIU | Vial |
| 16 | Colistimethate Sodium BP | COLIPRIME 2 MIU | Vial |
| 17 | Colistimethate Sodium BP | COLIPRIME 3 MIU | Vial |
| 18 | Doripenem 500 mg | DORIJET 500mg Inj. | Vial |
| 19 | Esomeprazole Sodium 40 mg | ESOPOWER Inj. | Vial |
| 20 | Esomeprazole Sodium 40 mg | ESOPOWER Tab. | Vial |
| 21 | Esomeprazole Sodium 40 mg + Levosulpiride 75mg | ESOPOWER-L | Vial |
| 22 | Glutathione BP 600 mg | XETOX - 600 mg.Inj | Vial |
| 23 | Glutathione BP 500 mg | XETOX - TAB | Vial |
| PRODUCT LIST | |||
|---|---|---|---|
| SR NO | GENERIC NAME /COMPOSITION | BRAND NAME | PKG |
| 24 | Hydrocortisone Sod. Succinate 100mg. | HYDROLIN 100mg. Inj. | Vial |
| 25 | Imipenem - 500mg. + Cilastatin - 500mg. | IMIJET Inj. | Vial |
| 26 | Liposomal Amphotericin - B 50mg | LIPHOLYN Inj 50mg | Vial |
| 27 | Meropenem Trihydrate 1g. | MEROJET 1g. Inj. | Vial |
| 28 | Meropenem Trihydrate 1g. | MEROECO 1g Inj. | Vial |
| 29 | Meropenem Trihydrate 500mg. | MEROJET 500mg. Inj. | Vial |
| 30 | Meropenem Trihydrate 125mg. | MEROJET 125mg. Inj. | Vial |
| 31 | Meropenem Trihydrate 250mg. | MEROJET 250mg. Inj. | Vial |
| 32 | Omeprazole Sodium 40mg. | LYOM 40mg. Inj. | Vial |
| 33 | Pantoprazole Sodium 40mg. | LYPAN 40mg. Inj. | Vial |
| 34 | Piperacillin Sodium 2g. + Tazobactam Sodium 0.25g. | LYPITAZ 2.250g. Inj. | Vial |
| 35 | Piperacillin Sodium 4g. + Tazobactam Sodium 0.5g. | LYPITAZ 4.5g. Inj. | Vial |
| 36 | Piperacillin Sodium 4g. + Tazobactam Sodium 0.5g. | RUPIBACT 4.5g.Inj. | Vial |
| 37 | Ceftriaxone Sodium 1g +Sulbactam Sodium 500mg. | XOLYCEF - SB 1.5g. Inj. | Vial |
| 38 | Rabeprazole Sodium 20mg. | LYRAB 20mg. Inj. | Vial |
| 39 | Rabeprazole Sodium 20mg. | LYRAB Tab | Vial |
| 40 | Rabeprazole Sodium 20mg.+ Levosulpiride 75mg | L-LYRAB | Vial |
| 41 | Rabeprazole Sodium 20mg.+ Domperidone 30mg | LYRAB-D | Vial |
| 42 | Teicoplanin 200mg. | LYCOPLAN 200 Inj. | Vial |
| 43 | Teicoplanin 400mg. | LYCOPLAN 400 Inj. | Vial |
| 44 | Tigecycline 50mg | TIGIBRIL 50mg Inj. | Vial |
| 45 | Vancomycin Hydrochloride 500mg. | VANCOLYM 500mg. Inj. | Vial |
| 46 | Voriconazole Inj. 200mg. | VORILYN Inj. 200mg | Vial |
Animal Healthcare Division
Our integrated innovative solutions for Livestock
We market high quality, effective medicines, and feed supplements for Livestock.
We provide compassionate care, we focus on excellence with integrity and continued commitment to serve with values. we have wide range of products that satisfy needs of the Veterinarians and Animal owners to maintain and optimize health, Enhance the productivity, prevent and cure diseases in Animals.
We are successful in efficiently creating the value for farmers, veterinarians, stakeholders, and society as a whole.
Compassion
“We value the well-being of all people and animals and aim to treat everyone with dignity, and caring.”
Dedication
“We are determined to do all that is possible to produce the best possible patient outcome.”
| Best-in-Class Products of LYKA | |
|---|---|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Lyka BDR International
INTRODUCTION
Globally Lyka has its presence as Lyka BDR International Limited, with the focus in the business of manufacturing and marketing of finished pharmaceutical formulations, ready-to-fill lyophilized sterile API’s etc. Lyka BDR International markets over 150 formulations in various dosage forms.
It has over 600 product registrations in 30 markets and over 200 formulations are in their final stage of registrations in various markets. Lyka BDR enjoys good brand equity in the markets they operate in. Lyka BDR is the largest seller of Human and Veterinary Products in Sudan.
COUNTRIES OF OPERATION
Some of their important markets include :
In-Licencing Opportunity
We look for high potential differentiated and novel products for India Market.
Lyka Labs Ltd along with its other subsidiary has strong presence in Indian market in diverse therapeutic segments Lyka actively seeks to in-license products in various therapeutic segment particularly tablets & capsules which are of high quality & reliability. If you have a technology or a product to offer for licensing, please provide details on below email
Out-Licencing
We Lyka has a strong Research and Development setup with an eclectic pipeline of products including:
Differentiated Dermatological formulation (Based on Novel Drug Delivery Technologies)
Topical drug formulation
Cosmeceutical formulation
Platform Technologies in dermatology
Topical Stem cells products
Lyophilized Injections
Dry Powder Injections
MUTUALLY REWARDING PARTNERSHIP
We seek to establish long-term and mutually rewarding partnership with companies having complementary capacities to make such products available globally.
The models that we generally follow in our Out Licensing activities are :
Manufacturing
Loan & Licensing
If you have a requirement of product, please provide details on
DINU1861
DINU1862
DINU1858
DINU1856
DINU1857
DINU1854
DINU1855
DINU1853
DINU1852
DINU1851
DINU1847
DINU1848
DINU1849
DINU1845
DINU1846
DINU1843
DINU1844
DINU1841
DINU1842
DINU1840
DINU1838
DINU1839
DINU1835
DINU1836
DINU1837
DINU1834
DINU1833
DINU1830
DINU1831
DINU1832
DINU1826
DINU1829
DINU1825
DINU1822
DINU1824
DINU1820
DINU1821
DINU1818
DINU1819
DINU1812
DINU1813
DINU1814
DINU1810
DINU1811
DINU1808
DINU1809
DINU1807
DINU1805
DINU1806
DINU1802
DINU1804
DINU1801
DINU1799
DINU1795
DINU1791
DINU1792
DINU1793
DINU1794
